Date of submission of the HTAC Recommendation: 01 June 2026Date of notification to HTAC on the SOH decision: 21 September 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on (1) Paroxetine [20 mg tablet and 20 mg film-coated tablet] and (2) Vortioxetine [5mg, 10mg, 15mg, 20mg film-coated tablet] continue reading : HTA Council Final Recommendation Paroxetine (20 mg tablet and 20 mg film-coated tablet) and Vortioxetine (5 mg, 10mg, 15mg, 20mg film-coated tablet) for the treatment of mental health conditions
HTA Council Final Recommendation on Iopromide 623.40 mg/mL and 768.86 mg/mL in 500 mL clear glass infusion bottle for use as contrast media
Date of submission of the HTAC Recommendation: 14 May 2026Date of notification to HTAC on the SOH decision: 17 August 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on Iopromide (1) 623.40 mg/mL (equivalent to 300 mg iodine) and (2) 768.86 mg/mL (equivalent to 370 mg iodine) in continue reading : HTA Council Final Recommendation on Iopromide 623.40 mg/mL and 768.86 mg/mL in 500 mL clear glass infusion bottle for use as contrast media